Clik here to view.
Akebia Announces Positive Top-Line Results from its Phase 2b Study of...
CAMBRIDGE, Mass. Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia...
View ArticleClik here to view.
Akebiaが慢性腎臓病に関連した貧血を伴う非透析患者を対象にAKB-6548を検討した第2b相試験で、優れて良好な結果が得られたと発表
米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 低酸素誘導因子（HIF）の生物学を通じて腎臓病患者に革新的治療薬を提供することに傾注するバイオ製薬企業のAkebia Therapeutics,...
View ArticleClik here to view.
可口可乐邀请全世界“分享无艾滋病一代的声音”并支持(RED)
亚特兰大 (美国商业资讯)–可口可乐公司与(RED)携手推出了一项名为“分享无艾滋病一代的声音(SHARE THE SOUND OF AN AIDS FREE...
View ArticleClik here to view.
コカ・コーラ、エイズフリー世代を実現する運動「SHARE THE SOUND OF AN AIDS FREE...
アトランタ （ビジネスワイヤ） — ザ コカ・コーラ カンパニーは、(RED)と協力して、HIV母子感染の撲滅を目指す新しいキャンペーン「SHARE THE SOUND OF AN AIDS FREE...
View ArticleClik here to view.
AHF Global World AIDS Day Events Focus On Testing and Treatment
PHOTO: For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty...
View ArticleClik here to view.
Clik here to view.
AHF在世界艾滋病日开展全球性活动，侧重于检测和治疗
(美国商业资讯) — 图片：在世界艾滋病日，AHF将在全球开展160多场活动，来推动HIV/艾滋病的检测和治疗；国际性的纪念活动将开展全球性运动，在2020年底前使2千万HIV阳性人士获得治疗。有关进一步信息，请访问www.aidshealth.org/wad （点击“世界各地的活动”标签查看国际性活动的列表。）...
View ArticleClik here to view.
ansarada Pledges 1 Percent of Its Equity to Adara
SYDNEY ansarada, the technology company whose goal is to revolutionize the world of mergers and acquisitions (M&A), is pledging 1 percent of its equity, time and product to the Adara Group, a...
View ArticleClik here to view.
OMT Therapeutics Announces UniRat™ Alliance with Caltech
PALO ALTO, Calif. OMT Therapeutics, Inc. (OMT Therapeutics) today announced a partnership with the California Institute of Technology (Caltech) under which Caltech will use OMT Therapeutics’ fully...
View ArticleClik here to view.
THERAVECTYS to Present Detailed Phase I/II Results from the First-Ever...
PARIS THERAVECTYS, a Paris-based, fully-integrated discovery & clinical development company specialized in lentiviral vector-based therapeutic vaccines and T-cell therapies announced that...
View ArticleClik here to view.
テラヴェクティス、レンチウイルスベクターを使用した治療用ワクチンの初の第I/II相試験から得た詳細結果を2015年HIV治療シンポジウムで発表へ
パリ （ビジネスワイヤ） — パリを拠点とする完全統合型の創薬・臨床開発企業としてレンチウイルスベクターを使用した治療用ワクチンとT細胞療法を専門とするテラヴェクティスは本日、当社の第I/II相試験から得た詳細結果を、 「第8回国際エイズ学会HIV基礎研究・治療・予防会議」（IAS...
View ArticleClik here to view.
EU Marketing Approval Granted for VivaGel® BV
MELBOURNE, Australia Starpharma (ASX: SPL) (OTCQX: SPHRY) today announced it has received, overnight, marketing approval in the European Union (EU) for VivaGel® BV for the treatment and rapid relief...
View ArticleClik here to view.
Amoy Diagnostics and Illumina Enter Strategic Collaboration for...
XIAMEN, China & SAN DIEGO Amoy Diagnostics Co. Ltd. (ADx) and Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration to accelerate the adoption of precision medicine and...
View ArticleClik here to view.
AHF Marks World AIDS Day with HIV Testing & Awareness Events in 32 Countries;...
LOS ANGELES AIDS Healthcare Foundation (AHF), the largest global AIDS organization, will commemorate World AIDS Day on December 1 through dozens of free HIV awareness and testing events throughout...
View ArticleClik here to view.
AHF: New UN Report Says Hook Up Apps Fuel Global Increase in HIV, STDs; Apps...
LOS ANGELES The United Nations recently announced the results of a two-year study that found the growing use of mobile dating apps by young gay men is a major factor in a new HIV epidemic among...
View ArticleClik here to view.
Biosantech的抗HIV候选疫苗IIA期临床试验结果在《逆转录病毒学》上发表
法国索菲亚科技园 (美国商业资讯) — Biosantech的抗HIV候选疫苗IIA期临床试验主要目的是表明三联疗法暂停后，给予疫苗可降低病毒血症恢复及促病毒DNA，该试验的详细结果刚刚在科学期刊《逆转录病毒学》上发表。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
ビオサンテックの抗HIVワクチン候補を検討する第IIA相臨床試験の結果がRetrovirologyに掲載
仏ソフィア・アンティポリス （ビジネスワイヤ） — ビオサンテックの抗HIVワクチン候補の第IIA相臨床試験は、3剤併用療法の一時休止後のウイルス血症再発とプロウイルスDNAの低減を証明することを主たる目的としていますが、その詳細結果が科学誌のRetrovirologyに今般発表されました。 このSmart News...
View ArticleClik here to view.
Illumina Registers MiSeqDx System in South Korea
SAN DIEGO Illumina, Inc. (NASDAQ: ILMN) today announced it has received a product approval certificate for the MiSeqDx® Instrument and the MiSeqDx Universal Kit with the Ministry of Food and Drug...
View ArticleClik here to view.
Australian Olympic Team Taking Dual Protect™ VivaGel® Condoms to Rio
MELBOURNE, Australia Starpharma Holdings Ltd (ASX:SPL) (OTCQX:SPHRY) and Ansell Limited (ASX:ANN) today proudly announce that the Australian Olympic team will be provided with antiviral Dual...
View ArticleClik here to view.
Report on Value of Innovation to HIV/AIDS Treatments in Low- and...
GENEVA A report by Charles River Associates (CRA) provides an analysis of the factors that impact access to HIV/AIDS treatments and the role of bio-pharmaceutical innovation in Low-and Middle-Income...
View Article